Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

During the Trading Day
144.81 +1.65 / +1.15%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
144.35 -0.46 / -0.32%
 
Volume: 51.3K
AMGN Regular Dividend: AMGN will begin trading ex-dividend on 02/11/16 with a $1.00 dividend payable to shareholders of record as of 02/16/16.

Today’s Trading

Previous close143.16
Today’s open145.21
Day’s range143.96 - 147.13
Volume4,273,459
Average volume (3 months)3,839,856
Market cap$108.0B
Dividend yield2.76%
Data as of 3:59pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+7.30%
P/E ratio17.3
Price/Sales6.12
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.55+0.63%
BIIBBiogen+2.21+0.88%
BXLTBaxalta Inc+0.68+1.85%
BAXBaxter International...+0.72+1.99%
Data as of 4:01pm ET, 02/10/2016

Financials

Next reporting dateApril 19, 2016
EPS forecast (this quarter)$2.59
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers